| 1.74 0.01 (0.58%) | 03-12 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 2.59 | 1-year : | 3.02 |
| Resists | First : | 2.22 | Second : | 2.59 |
| Pivot price | 1.15 |
|||
| Supports | First : | 1.23 | Second : | 0.62 |
| MAs | MA(5) : | 1.77 |
MA(20) : | 1.04 |
| MA(100) : | 1.32 |
MA(250) : | 2.39 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 73.9 |
D(3) : | 74.7 |
| RSI | RSI(14): 68.5 |
|||
| 52-week | High : | 6 | Low : | 0.62 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AIFF ] has closed below upper band by 21.6%. Bollinger Bands are 231.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.75 - 1.76 | 1.76 - 1.77 |
| Low: | 1.56 - 1.57 | 1.57 - 1.58 |
| Close: | 1.73 - 1.74 | 1.74 - 1.75 |
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Thu, 12 Mar 2026
Firefly Neuroscience Raises $2.25 Million; Investors May Add Up to $18 Million in 30 Days - TradingView
Fri, 06 Mar 2026
What's Going On With Firefly Neuroscience Stock On Friday? - Benzinga
Fri, 06 Mar 2026
What's Driving the Market Sentiment Around Firefly Neuroscience Inc? - Sahm
Thu, 05 Mar 2026
Firefly Neuroscience Stock Dips with Market Challenges in 2025 - timothysykes.com
Thu, 05 Mar 2026
Firefly Neuroscience stock jumps 126% after Nvidia GPU push and 33-fold brain-scan surge - TechStock²
Wed, 04 Mar 2026
Firefly Neuroscience (AIFF) jumps 126.3% as investors react to new growth update and heavy volume - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 1.184e+007 (%) |
| Held by Institutions | 25.6 (%) |
| Shares Short | 444 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.65e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -632.5 % |
| Return on Assets (ttm) | -61.5 % |
| Return on Equity (ttm) | -340.9 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -2.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 391330 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |